Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Antibodies to melanoma cell and BCG antigens in sera from tumour-free individuals and from melanoma patients

Abstract

THE Mycobacterium bovis strain BCG shares antigenic components with several neoplasms, including human malignant melanoma1–5. Other species of bacteria also have antigenic similarities with a guinea pig hepatoma6. Antibodies to mycobacteria and other bacterial antigens are universally present in sera from normal humans7,8. Since there is a broad range of shared or cross-reactive antigens among mycobacteria and unrelated microorganisms9, it is conceivable that an immune response by normal humans to mycobacteria has been induced by exposure to taxonomically unrelated microorganisms ubiquitous in the environment. Cytotoxic reactions by lymphoid cells from normal animals and humans to many kinds of tumour cells have been reported10–15. Antibodies in sera from patients with various neoplasms have often been observed that react with antigens derived from their own tumours or from those of the same histological type16–18.Humoral responses to tumour-associated antigens have also been noted in sera from normal humans, gibbons and mice19–21. We have investigated whether sera from normal, tumour-free humans contain antibodies which can react with melanoma-associated as well as with BCG antigens. If this were the case, perhaps immunological reactions by normal humans to certain tumours are widespread and reflect previous sensitisation by microorganisms.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Borsos, T., and Rapp, H. J., J. natn. Cancer Inst., 51, 1085–1086 (1973).

    Article  CAS  Google Scholar 

  2. Bucana, C., and Hanna, M. G., Jr, J. natn. Cancer Inst., 53, 1313–1323 (1974).

    Article  CAS  Google Scholar 

  3. Minden, P., McClatchy, J. K., Wainberg, M., and Weiss, D. W., J. natn. Cancer Inst., 53, 1325–1331 (1974).

    Article  CAS  Google Scholar 

  4. Minden, P., Sharpton, T. R., and McClatchy, J. K., J. Immun., 116, 1407–1414 (1976).

    CAS  PubMed  Google Scholar 

  5. Lewis, M. G., et al., in The Present Status of BCG in Cancer Immunotherapy (edit. by Lamoureux, E. G., Portelance, V., and Turcotte, R.), (Grune and Stratton, New York, 1976).

    Google Scholar 

  6. Minden, P., Sharpton, T. R., and McClatchy, J. K., Cancer Res., 36, 1680–1685 (1976).

    CAS  PubMed  Google Scholar 

  7. Bardana, E. J., McClatchy, J. K., Farr, R. S., and Minden, P., Clin., exp. Immun., 13, 65–77 (1973).

    Google Scholar 

  8. Minden, P., and Farr, R. S., Chest, 68, 749–750 (1975).

    Article  CAS  Google Scholar 

  9. Minden, P., McClatchy, J. K., Cooper, R., Bardana, E. J., and Farr, R. S. Science, 176, 57–58 (1972).

    Article  ADS  CAS  Google Scholar 

  10. Blair, P. B., Lane, M. A., and Yagi, M. J., J. Immun., 112, 693–705 (1974).

    CAS  PubMed  Google Scholar 

  11. Herberman, R. B., Nunn, M. E., Holden, H. T., and Lavrin, D. H., Int. J. Cancer, 16, 216–229 (1975).

    Article  CAS  Google Scholar 

  12. Kiesling, R., Klein, E., and Wigzell, H., Eur. J. Immun., 5, 112–121 (1975).

    Article  Google Scholar 

  13. Tagasugi, M., Mickey, M. R., and Terasaki, P. I., Cancer Res., 33, 2898–2902 (1973).

    Google Scholar 

  14. de Vries, J. E., Meyering, M., van Dongen, A., and Rumke, P., Int. J. Cancer, 15, 391–400 (1975).

    Article  CAS  Google Scholar 

  15. Canevari, S., Fossati, G., and Della Porta, G., J. natn. Cancer Inst., 56, 705–709 (1976).

    Article  CAS  Google Scholar 

  16. Hellström, I., Hellström, K. E., Pierce, G. E., and Yang, J. P. S., Nature, 220, 1352–1354 (1968).

    Article  ADS  Google Scholar 

  17. Lewis, M. G., Med. Clinics of North America, 56, 481–499 (1972).

    Article  CAS  Google Scholar 

  18. Bodurtha, A. J., Chee, D. O., Laucius, J. F., Mastrangelo, M. J., and Prehn, R. T., Cancer Res., 35, 189–193 (1975).

    CAS  PubMed  Google Scholar 

  19. Bias, W. B., Santos, G. W., Burke, P. J., Mullins, G. M., and Humphrey, R. L., Science, 178, 304–306 (1972).

    Article  ADS  CAS  Google Scholar 

  20. Aoki, T., et al., Science, 19, 1180–1183 (1976).

    Article  ADS  Google Scholar 

  21. Hanna, M. G., Jr, Ihle, J. N., Batzing, B. L., Tennant, R. W., and Schenley, C. K., Cancer Res., 35, 164–171 (1975).

    PubMed  Google Scholar 

  22. Minden, P., Farr, R. S., and Trembath, J., Immunochemistry, 12, 477–479 (1975).

    Article  CAS  Google Scholar 

  23. Dixon, F. J., The Harvey Lectures, 58, 21 (Academic, New York, 1963).

    Google Scholar 

  24. Lewis, M. G., Phillips, T. M., Cook, K. B., and Blake, J., Nature, 232, 52–53 (1971).

    Article  ADS  CAS  Google Scholar 

  25. Rowley, D. A., Fitch, F. W., Stuart, F. P., Kohler, H., and Cosenza, H., Science, 181, 1133–1141 (1973).

    Article  ADS  CAS  Google Scholar 

  26. Lewis, M. G., Hartmann, D., and Jerry, L. M., Proc. N. Y. Acad. Sci., (in the press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

MINDEN, P., JARRETT, C., MCCLATCHY, J. et al. Antibodies to melanoma cell and BCG antigens in sera from tumour-free individuals and from melanoma patients. Nature 263, 774–777 (1976). https://doi.org/10.1038/263774a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/263774a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing